These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 37248463)

  • 1. Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT.
    Nagler A; Labopin M; Blaise D; Raiola AM; Corral LL; Bramanti S; Sica S; Kwon M; Koc Y; Pavlu J; Kulagin A; Busca A; Rodríguez AB; Reményi P; Schmid C; Brissot E; Sanz J; Bazarbachi A; Giebel S; Ciceri F; Mohty M
    J Hematol Oncol; 2023 May; 16(1):58. PubMed ID: 37248463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Nagler A; Labopin M; Houhou M; Aljurf M; Mousavi A; Hamladji RM; Al Zahrani M; Bondarenko S; Arat M; Angelucci E; Koc Y; Gülbas Z; Sica S; Bourhis JH; Canaani J; Brissot E; Giebel S; Mohty M
    J Hematol Oncol; 2021 Apr; 14(1):53. PubMed ID: 33794963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haploidentical transplantation outcomes for secondary acute myeloid leukemia: Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) study.
    Li Z; Labopin M; Ciceri F; Blaise D; Tischer J; Ehninger G; Van Lint MT; Koc Y; Santarone S; Forcade E; Castagna L; Polge E; Mailhol A; Ruggeri A; Mohty M; Savani BN; Nagler A
    Am J Hematol; 2018 Jun; 93(6):769-777. PubMed ID: 29536560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haploidentical transplantation in primary refractory/relapsed secondary vs de novo AML: from the ALWP/EBMT.
    Nagler A; Labopin M; Tischer J; Raiola AM; Kunadt D; Vydra J; Blaise D; Chiusolo P; Fanin R; Winkler J; Forcade E; Van Gorkom G; Ciceri F; Mohty M
    Blood Adv; 2024 Aug; 8(15):4223-4233. PubMed ID: 38598754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparable relapse incidence after unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide versus conventional anti-graft versus host disease prophylaxis in patients with acute myeloid leukemia: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Nagler A; Ngoya M; Galimard JE; Labopin M; Blau IW; Kröger N; Gedde-Dahl T; Schroeder T; Burns D; Salmenniemi U; Rambaldi A; Choi G; Peffault de Latour R; Vydra J; Sengeloev H; Eder M; Mielke S; Forcade E; Kulagin A; Ciceri F; Mohty M
    Am J Hematol; 2024 Sep; 99(9):1732-1745. PubMed ID: 38856236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMT.
    Baron F; Labopin M; Tischer J; Raiola AM; Vydra J; Blaise D; Chiusolo P; Stölzel F; Fanin R; Chevallier P; Nagler A; Ciceri F; Mohty M
    J Hematol Oncol; 2023 Feb; 16(1):10. PubMed ID: 36782226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study.
    Baron F; Nagler A; Galimard JE; Sanz J; Versluis J; Forcade E; Chevallier P; Sirvent A; Anthias C; Kuball J; Furst S; Rambaldi A; Sierra J; von dem Borne PA; Gallego Hernanz MP; Cluzeau T; Robinson S; Raiola AM; Labussière-Wallet H; Byrne JL; Malfuson JV; Ruggeri A; Mohty M; Ciceri F
    Br J Haematol; 2024 Jan; 204(1):250-259. PubMed ID: 37784256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT.
    Sanz J; Galimard JE; Labopin M; Afanasyev B; Angelucci E; Ciceri F; Blaise D; Cornelissen JJ; Meijer E; Diez-Martin JL; Koc Y; Rovira M; Castagna L; Savani B; Ruggeri A; Nagler A; Mohty M;
    J Hematol Oncol; 2020 May; 13(1):46. PubMed ID: 32375860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell-depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT).
    Sestili S; Labopin M; Ruggeri A; Velardi A; Ciceri F; Maertens J; Kanz L; Aversa F; Lewalle P; Bunjes D; Mohty M; Nagler A
    Cancer; 2018 May; 124(10):2142-2150. PubMed ID: 29469924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia.
    Schmaelter AK; Labopin M; Socié G; Itälä-Remes M; Blaise D; Yakoub-Agha I; Forcade E; Cornelissen J; Ganser A; Beelen D; Labussière-Wallet H; Passweg J; Savani BN; Schmid C; Nagler A; Mohty M
    Blood Cancer J; 2020 Mar; 10(3):26. PubMed ID: 32127519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-Transplant Cyclophosphamide Combined with Anti-Thymocyte Globulin as Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome.
    Alanazi W; Chen S; Lipton JH; Kim DD; Viswabandya A; Kumar R; Lam W; Law AD; Al-Shaibani Z; Mattsson J; Michelis FV
    Acta Haematol; 2021; 144(1):66-73. PubMed ID: 32428903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic stem cell transplantation for patients with acute myeloid leukemia (AML) in second complete remission (CR2) transplanted from unrelated donors with post-transplant cyclophosphamide (PTCy). A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Nagler A; Labopin M; Swoboda R; Kulagin A; Labussière-Wallet H; Rovira M; Blaise D; Vydra J; Yakoub-Agha I; Choi G; Reményi P; Koc Y; Sanz J; Ciceri F; Mohty M
    Bone Marrow Transplant; 2023 May; 58(5):552-557. PubMed ID: 36823454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-T depleted haploidentical stem cell transplantation in AML patients achieving first complete remission after one versus two induction courses: a study from the ALWP/EBMT.
    Nagler A; Labopin M; Huang XJ; Blaise D; Arcese W; Araujo MC; Socié G; Forcade E; Ciceri F; Canaani J; Giebel S; Brissot E; Caballer JS; Bazarbachi A; Yakoub-Agha I; Mohty M
    Bone Marrow Transplant; 2022 Apr; 57(4):572-578. PubMed ID: 35105964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparable outcomes post allogeneic hematopoietic cell transplant for patients with de novo or secondary acute myeloid leukemia in first remission.
    Michelis FV; Atenafu EG; Gupta V; Kim DD; Kuruvilla J; Lipton JH; Loach D; Seftel MD; Uhm J; Alam N; Lambie A; McGillis L; Messner HA
    Bone Marrow Transplant; 2015 Jul; 50(7):907-13. PubMed ID: 25822226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haploidentical Transplantation for Older Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome.
    Ciurea SO; Shah MV; Saliba RM; Gaballa S; Kongtim P; Rondon G; Chen J; Wallis W; Cao K; Konopleva M; Daver N; Cortes J; Ravandi F; Alousi A; Ahmed S; Popat U; Parmar S; Bashir Q; Betul O; Hosing C; Shpall EJ; Rezvani K; Khouri IF; Kebriaei P; Champlin RE
    Biol Blood Marrow Transplant; 2018 Jun; 24(6):1232-1236. PubMed ID: 28918304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AML.
    Shimoni A; Labopin M; Angelucci E; Blaise D; Ciceri F; Koc Y; Gülbas Z; Diez-Martin JL; Bruno B; Castagna L; Martino M; Rovira M; Mohty M; Nagler A
    Bone Marrow Transplant; 2022 Mar; 57(3):384-390. PubMed ID: 35022535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Cytogenetic Risk on Outcomes of Non-T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia.
    Nagler A; Labopin M; Dholaria B; Ciceri F; Fraccaroli A; Blaise D; Fanin R; Bruno B; Forcade E; Vydra J; Chevallier P; Bulabois CE; Jindra P; Bornhäuser M; Canaani J; Sanz J; Savani BN; Spyridonidis A; Giebel S; Brissot E; Bazarbachi A; Esteve J; Mohty M
    Transplant Cell Ther; 2022 Nov; 28(11):773.e1-773.e8. PubMed ID: 36031079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission.
    Rashidi A; Hamadani M; Zhang MJ; Wang HL; Abdel-Azim H; Aljurf M; Assal A; Bajel A; Bashey A; Battiwalla M; Beitinjaneh AM; Bejanyan N; Bhatt VR; Bolaños-Meade J; Byrne M; Cahn JY; Cairo M; Ciurea S; Copelan E; Cutler C; Daly A; Diaz MA; Farhadfar N; Gale RP; Ganguly S; Grunwald MR; Hahn T; Hashmi S; Hildebrandt GC; Holland HK; Hossain N; Kanakry CG; Kharfan-Dabaja MA; Khera N; Koc Y; Lazarus HM; Lee JW; Maertens J; Martino R; McGuirk J; Munker R; Murthy HS; Nakamura R; Nathan S; Nishihori T; Palmisiano N; Patel S; Pidala J; Olin R; Olsson RF; Oran B; Ringden O; Rizzieri D; Rowe J; Savoie ML; Schultz KR; Seo S; Shaffer BC; Singh A; Solh M; Stockerl-Goldstein K; Verdonck LF; Wagner J; Waller EK; De Lima M; Sandmaier BM; Litzow M; Weisdorf D; Romee R; Saber W
    Blood Adv; 2019 Jun; 3(12):1826-1836. PubMed ID: 31201170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia.
    Dholaria B; Labopin M; Sanz J; Ruggeri A; Cornelissen J; Labussière-Wallet H; Blaise D; Forcade E; Chevallier P; Grassi A; Zubarovskaya L; Kuball J; Ceballos P; Ciceri F; Baron F; Savani BN; Nagler A; Mohty M
    J Hematol Oncol; 2021 May; 14(1):76. PubMed ID: 33941226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparable outcome after haploidentical and HLA-matched allogeneic stem cell transplantation for high-risk acute myeloid leukemia following sequential conditioning-a matched pair analysis.
    Doppelhammer M; Fraccaroli A; Prevalsek D; Bücklein V; Häbe S; Schulz C; Hubmann M; Hausmann A; Claus R; Rank A; Schmid C; Tischer J
    Ann Hematol; 2019 Mar; 98(3):753-762. PubMed ID: 30617644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.